Nephros (NEPH) Cost of Revenue (2010 - 2026)

Nephros' Cost of Revenue history runs 17 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 28.79% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $7.7 million (up 31.46% YoY), while the FY2025 annual figure was $7.2 million, up 31.72% from the prior year.
• Cost of Revenue for Q1 2026 stood at $2.2 million, up from $2.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $2.2 million in Q1 2026, with the low at $1.0 million in Q4 2022.
• The 5-year median for Cost of Revenue is $1.5 million (2023), against an average of $1.5 million.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue soared 46.82% in 2022, then declined 15.83% in 2024.
• Nephros' Cost of Revenue stood at $1.0 million in 2022, then advanced by 17.54% to $1.2 million in 2023, then climbed by 13.14% to $1.4 million in 2024, then surged by 41.08% to $2.0 million in 2025, then climbed by 12.75% to $2.2 million in 2026.
• Business Quant data shows NEPH's Cost of Revenue at $2.2 million in Q1 2026, $2.0 million in Q4 2025, and $1.8 million in Q3 2025.